Celluma Light Therapy by BioPhotas Revenue and Competitors
Estimated Revenue & Valuation
- Celluma Light Therapy by BioPhotas's estimated annual revenue is currently $11.3M per year.
- Celluma Light Therapy by BioPhotas's estimated revenue per employee is $251,000
Employee Data
- Celluma Light Therapy by BioPhotas has 45 Employees.
- Celluma Light Therapy by BioPhotas grew their employee count by 5% last year.
Celluma Light Therapy by BioPhotas's People
Name | Title | Email/Phone |
---|
Celluma Light Therapy by BioPhotas Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Celluma Light Therapy by BioPhotas?
More than a handheld, more than a mask: Celluma's innovative flexible panel design optimizes delivery of our pulsing, polychromatic light energy for use anywhere on the body. Medically credentialed and award-winning, Celluma is the global leader in advanced light therapy. Used by medical, aesthetic and wellness professionals around the world and by satisfied home users for skin care, wellness and pain relief! Celluma LED is advanced, award-winning light therapy for skin care & pain management. Safe, non-invasive and drug-free, the Celluma Series has 9 FDA-clearances and 9 medical CE marks, including those for treatment of Acne, Wrinkles and Pain. Additionally, the Celluma Series is medically CE marked for Dermal Wound Healing in Europe.
keywords:N/AN/A
Total Funding
45
Number of Employees
$11.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.9M | 45 | -10% | N/A |
#2 | $7.4M | 45 | -2% | N/A |
#3 | $7.6M | 45 | 5% | N/A |
#4 | $10.9M | 47 | 2% | N/A |
#5 | $10.9M | 47 | 7% | N/A |